Table 2.
Marker | Radiomics feature | r | FDR-adj p |
---|---|---|---|
CD3 | Qualitative features | ||
Tumour fat content | − 0.41 | 0.019 | |
CD31 | Texture features | ||
Pre variance 16 bins | − 0.47 | 0.005 | |
Pre information measure of correlation 2 16 bins | −0.38 | 0.038 | |
LAP maximal correlation 16 bins | −0.52 | 0.003 | |
Pre variance 64 bins | −0.47 | 0.005 | |
Quantitative features | |||
ERLVP | 0.37 | 0.023 | |
CD68 | Texture features | ||
Pre variance 16 bins | 0.33 | 0.047 | |
Pre sum average 16 bins | 0.41 | 0.018 | |
Pre sum variance 16 bins | 0.41 | 0.018 | |
Pre sum average 64 bins | 0.37 | 0.049 | |
Pre sum variance 64 bins | 0.42 | 0.017 | |
EAP sum entropy 64 bins | 0.45 | 0.049 | |
Qualitative features | |||
Mosaic appearance | 0.40 | 0.023 | |
Wash-in/wash-out | 0.37 | 0.042 | |
PD-L1 | Texture features | ||
ADC variance 64 bins | 0.41 | 0.029 | |
Quantitative features | |||
ERPVP | 0.42 | 0.015 | |
ER LVP | 0.47 | 0.005 |
Correlation coefficient coefficients (r) resulted from Spearman correlation analysis. p values were adjusted for multiple tests using a false discovery rate (FDR) adjustment
ADC = apparent diffusion coefficient, AUC = area under the curve, EAP = early arterial phase, ER = enhancement ratio, LAP = late arterial phase, LVP = late venous phase, PVP = portal venous phase